MOx 2.0 Case Study

Multiomic Testing Enables Precise Diagnosis for Niemann-Pick Type C1

Download Our Free CentoXome MOx 2.0 Case Study Today!

A success story from our multiomic Whole Exome Sequencing (WES) testing solution – CentoXome MOx 2.0. Check out our case study to see how CentoXome MOx 2.0 was able to establish a fast and definitive diagnosis by integrating WES with splicing analysis on RNA level and biochemical analytics.

First Name

Last Name

Country

By clicking “Download now” I agree that CENTOGENE will get in touch via email on latest news regarding our clinical diagnostics and scientific developments on rare diseases, including but not limited to upcoming events and commercial offers. I can withdraw my consent at any time for the future by clicking the “Unsubscribe” button in the emails or by contacting CENTOGENE directly.

Why Choose CentoXome MOx 2.0

Integrated genomic and biochemical testing facilitates the decision on the pathogenicity of clinical variants leading to higher diagnostic yield

Biochemical testing allows for orthogonal confirmation of disease – accelerating the path to a diagnosis by avoiding stepwise testing

Multiomics provides a complete clinical picture – enabling the assessment of disease severity and thus accelerating personalized treatments